PTC
AERI

Petrus Trust Company’s Aerie Pharmaceuticals AERI Stock Holding History

Petrus Trust Company’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,513
Closed -$96K – 163
2022
Q1 		$96K Buy
+10,513
New +$81K 0.01% 57

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Petrus Trust Company's AERI Position: Q2 2022 in Review

Petrus Trust Company sold out of Aerie Pharmaceuticals (AERI) in Q2 2022, closing a stake of 10,513 shares — an estimated $96K sold.

Petrus Trust Company first reported a position in AERI in Q1 2022 and held it in 1 quarter. The position peaked at $96K in Q1 2022. 137 funds tracked by Wall St. Rank hold AERI as of Q2 2022.

  • Petrus Trust Company reported no remaining Aerie Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Petrus Trust Company sold 10,513 Aerie Pharmaceuticals shares in Q2 2022, an estimated $96K.
  • Petrus Trust Company first reported a position in Aerie Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Petrus Trust Company's Aerie Pharmaceuticals position peaked at $96K in Q1 2022.
  • 137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2022.

Based on Petrus Trust Company's 13F filing for Q2 2022, filed 15 Aug 2022.